Nordea Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$727M Buy
5,260,363
+121,664
+2% +$17M 0.68% 30
2025
Q4
$630M Buy
5,138,699
+726,101
+16% +$88.2M 0.54% 31
2025
Q3
$494M Buy
4,412,598
+455,665
+12% +$51.8M 0.43% 48
2025
Q2
$437M Buy
3,956,933
+1,126,886
+40% +$120M 0.41% 60
2025
Q1
$317M Buy
2,830,047
+2,059,177
+267% +$212M 0.33% 82
2024
Q4
$71.1M Buy
770,870
+45,507
+6% +$4.1M 0.07% 226
2024
Q3
$61M Sell
725,363
-261,854
-27% -$20M 0.07% 237
2024
Q2
$67.9M Sell
987,217
-48,708
-5% -$3.25M 0.08% 235
2024
Q1
$76.2M Sell
1,035,925
-87,815
-8% -$6.75M 0.09% 225
2023
Q4
$91.1M Buy
1,123,740
+385,630
+52% +$30M 0.12% 188
2023
Q3
$55.8M Sell
738,110
-13,003
-2% -$1M 0.08% 224
2023
Q2
$57.5M Sell
751,113
-45,330
-6% -$3.62M 0.08% 220
2023
Q1
$65.1M Sell
796,443
-16,785
-2% -$1.39M 0.1% 197
2022
Q4
$69.4M Sell
813,228
-76,969
-9% -$6.1M 0.11% 190
2022
Q3
$56.2M Sell
890,197
-109,308
-11% -$6.89M 0.09% 201
2022
Q2
$61.6M Sell
999,505
-98,320
-9% -$6.09M 0.09% 198
2022
Q1
$65.7M Sell
1,097,825
-41,082
-4% -$2.63M 0.08% 212
2021
Q4
$83.4M Buy
1,138,907
+63,845
+6% +$4.4M 0.1% 201
2021
Q3
$76.4M Buy
1,075,062
+1,012
+0.1% +$71.1K 0.1% 201
2021
Q2
$74M Buy
1,074,050
+1,166
+0.1% +$77.9K 0.1% 203
2021
Q1
$69.4M Sell
1,072,884
-203,610
-16% -$13.1M 0.1% 198
2020
Q4
$74.4M Sell
1,276,494
-14,807
-1% -$893K 0.12% 178
2020
Q3
$80.7M Sell
1,291,301
-455,341
-26% -$31.6M 0.15% 145
2020
Q2
$132M Buy
1,746,642
+887,810
+103% +$68M 0.14% 147
2020
Q1
$64.2M Sell
858,832
-29,666
-3% -$2.05M 0.15% 130
2019
Q4
$57.3M Sell
888,498
-9,537
-1% -$621K 0.11% 174
2019
Q3
$56.9M Sell
898,035
-4,693
-0.5% -$307K 0.12% 159
2019
Q2
$61M Sell
902,728
-193,043
-18% -$12.7M 0.14% 151
2019
Q1
$71.2M Buy
1,095,771
+69,597
+7% +$4.63M 0.15% 137
2018
Q4
$64.2M Buy
1,026,174
+127,140
+14% +$8.89M 0.15% 126
2018
Q3
$69.4M Sell
899,034
-19,018
-2% -$1.44M 0.14% 123
2018
Q2
$65M Sell
918,052
-3,202
-0.3% -$226K 0.16% 113
2018
Q1
$69.5M Sell
921,254
-14,628
-2% -$1.16M 0.17% 114
2017
Q4
$67M Sell
935,882
-259,583
-22% -$19.7M 0.16% 116
2017
Q3
$96.9M Buy
1,195,465
+205,250
+21% +$15.7M 0.23% 95
2017
Q2
$70.1M Sell
990,215
-722,386
-42% -$48.1M 0.18% 114
2017
Q1
$116M Sell
1,712,601
-711,076
-29% -$50M 0.31% 77
2016
Q4
$174M Sell
2,423,677
-6,576
-0.3% -$489K 0.46% 54
2016
Q3
$192M Buy
2,430,253
+73,904
+3% +$6M 0.5% 51
2016
Q2
$197M Sell
2,356,349
-63,962
-3% -$5.68M 0.55% 46
2016
Q1
$222M Buy
2,420,311
+413,849
+21% +$37.3M 0.67% 41
2015
Q4
$203M Buy
2,006,462
+99,087
+5% +$10.3M 0.69% 40
2015
Q3
$187M Buy
1,907,375
+62,536
+3% +$6.95M 0.69% 41
2015
Q2
$216M Buy
1,844,839
+63,704
+4% +$6.96M 0.76% 38
2015
Q1
$175M Sell
1,781,135
-6,590
-0.4% -$669K 0.63% 48
2014
Q4
$169M Buy
1,787,725
+678,739
+61% +$70.2M 0.62% 50
2014
Q3
$118M Buy
1,108,986
+6,236
+0.6% +$611K 0.47% 57
2014
Q2
$91.4M Sell
1,102,750
-6,668
-0.6% -$519K 0.38% 74
2014
Q1
$78.6M Buy
1,109,418
+15,515
+1% +$1.22M 0.37% 70
2013
Q4
$82.2M Sell
1,093,903
-80,498
-7% -$5.61M 0.41% 63
2013
Q3
$73.8M Sell
1,174,401
-183,767
-14% -$11M 0.41% 60
2013
Q2
$69.6M Buy
+1,358,168
New +$70.8M 0.43% 63

Other funds holding GILD

Nordea Investment Management's GILD Position: Q1 2026 in Review

Nordea Investment Management increased its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, buying an estimated $17M and bringing the position to 5,260,363 shares worth $727M. The position accounts for 0.68% of the portfolio, ranked #30.

Nordea Investment Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Nordea Investment Management held 5,260,363 shares of Gilead Sciences worth $727M as of Q1 2026.
  • Nordea Investment Management bought 121,664 Gilead Sciences shares in Q1 2026, an estimated $17M.
  • Gilead Sciences made up 0.68% of Nordea Investment Management's portfolio in Q1 2026, its #30 holding.
  • Nordea Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.